Erg cooperates with TGF-β to control mesenchymal differentiation

Area of Science:

• Skeletal biology and developmental genetics.
• Cell signaling pathways in development.

Background:

• Transforming growth factor β (TGF-β) signaling is essential for skeletal development.
• Conditional deletion of the TGF-β type II receptor (Tgfbr2) in Col2a+ cells disrupts annulus fibrosus (AF) development.
• Microarray analysis identified Erg as a candidate regulator of AF development.

Purpose of the Study:

• To investigate the role of TGF-β in AF differentiation.
• To elucidate the function of the transcription factor Erg in AF development.
• To understand the interplay between TGF-β signaling and Erg in sclerotome differentiation.

Main Methods:

• Primary mouse sclerotome micromass cultures treated with TGF-β.
• In vivo studies using TGF-β soaked Affi-gel beads in chick embryos.
• Adenovirus-mediated over-expression of Erg in sclerotome cultures.
• Alcian blue staining and gene expression analysis (Sox9, c-Maf, Sca1).
• Co-immunoprecipitation assays to assess protein interactions.

Main Results:

• TGF-β treatment induced AF marker expression in sclerotome cells and Erg expression both in vitro and in vivo.
• Erg over-expression altered cell morphology, inhibited hyaline cartilage differentiation, and upregulated Sca1.
• Co-expression of Erg and TGF-β treatment enhanced sclerotome differentiation markers.
• Erg was found to bind to Smad3, a key mediator of TGF-β signaling.

Conclusions:

• Erg is regulated by TGF-β signaling during AF development.
• Erg alone is insufficient to induce AF differentiation but can cooperate with TGF-β.
• Erg and Smad3 interaction provides a molecular mechanism for TGF-β/Erg cooperation in sclerotome differentiation.
• These findings offer insights into the molecular mechanisms governing intervertebral disc development.